Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

 

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

2015-03-22 06:59:40| Biotech - Topix.net

Amgen today announced that an application seeking marketing approval of RepathaTM for the treatment of high cholesterol has been submitted for review to the Ministry of Health, Labour and Welfare in Japan. Repatha is being developed in Japan by Amgen Astellas BioPharma K.K., a joint venture between Amgen and Astellas Pharma Inc., a pharmaceutical company headquartered in Tokyo.

Tags: of high japan marketing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

14.05 True Corporation has releases 1Q 2024 results 14.05 FuboTV releases results for quarter ended March 31, 2024 14.05 IDC forecasts slower growth for global telecoms market 14.05 Chunghwa Telecom reports results for the first quarter of 2024 14.05 Indorama Ventures Reports Improved Performance in 1Q 2024 14.05 UK wage growth still high despite unemployment rise 14.05 UK mining giant Anglo American unveils break-up plan 14.05 Workers leaving steel town as 2,000 job cuts loom More »